NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2 | -71.4% | 3 | 0.0% | 0.00% | – |
Q4 2022 | $7 | -99.6% | 3 | -97.1% | 0.00% | – |
Q3 2020 | $2,000 | -96.9% | 103 | -97.2% | 0.00% | -100.0% |
Q1 2020 | $65,000 | +38.3% | 3,652 | +70.8% | 0.00% | +100.0% |
Q4 2019 | $47,000 | +840.0% | 2,138 | +1325.3% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -58.3% | 150 | -57.1% | 0.00% | -100.0% |
Q1 2019 | $12,000 | +50.0% | 350 | +40.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -85.2% | 250 | -72.0% | 0.00% | -75.0% |
Q3 2018 | $54,000 | +20.0% | 894 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $45,000 | +800.0% | 894 | +1688.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 50 | -50.0% | 0.00% | -100.0% |
Q4 2017 | $6,000 | -14.3% | 100 | -75.0% | 0.00% | 0.0% |
Q3 2016 | $7,000 | +16.7% | 400 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $6,000 | +200.0% | 400 | +100.0% | 0.00% | 0.0% |
Q3 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $2,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |